100 results
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
mechanisms including cell death occurring through mitochondrial pore permeability (cyclophilin D). Inhibition of cyclophilin D, therefore, may play … an important role in protection from cell death. Cyclophilin A binding to CD147 is known to play a role in inflammation, cyclophilin B plays a role
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
24 Jul 23
Regulation FD Disclosure
4:04pm
common cancer - related death*905,000 new cases and830,000 deaths globally*30,000 new cases annually in U.S.* with 5 - year survival of 18 … fibrosis is well established Consequences of NASH may be severe (need for liver transplant, cancer, cardiovascular disease, and death)
8 NASH DISEASE
424B5
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Prospectus supplement for primary offering
4:39pm
fibrosis.
Cyclophilins are pleiotropic enzymes that play a role in injury and steatosis through mechanisms including cell death occurring through … injury and death. Cyclophilin A binding to CD147 is known to play a role in inflammation, cyclophilin B plays a role in fibrosis through collagen
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
22 May 23
Regulation FD Disclosure
1:05pm
hepatocellular carcinoma Most prevalent type (90%) of liver cancer & liver cancer is 2 most common cancer-related death*905,000 new cases and830,000 … (need for liver transplant, cancer, cardiovascular disease, and death)
8 NASH DISEASE PROGRESSION normal liver cells fatty liver cells inflammation
8-K
EX-99.1
kctr87u7qeha6om6n
17 Oct 22
Regulation FD Disclosure
5:13pm
DEFA14A
6f08 w6vr
14 Jun 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
41x8dbcz btg6gc3
27 May 22
Regulation FD Disclosure
8:44am
8-K
EX-99.1
9whv5z3 2jh
12 Jan 22
Hepion Pharmaceuticals Announces Death of Director, Thomas Adams
10:08am
8-K
y4kpi 8hwnugp6ayg0
12 Jan 22
Hepion Pharmaceuticals Announces Death of Director, Thomas Adams
10:08am
8-K
EX-99.1
1gu4i6gp
10 Jan 22
Regulation FD Disclosure
6:02am
8-K
EX-99
nco1p0yz
21 Dec 21
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver Cancer
8:25am
8-K
EX-99.1
xh8cn7pg
16 Nov 21
Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study
8:53am
8-K
EX-99.2
ococmaljv
10 Nov 21
Hepion Pharmaceuticals Announces Poster Details for the Upcoming AASLD The Liver Meeting® 2021
9:41am